Vanguard Personalized Indexing Management LLC Has $578,000 Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Vanguard Personalized Indexing Management LLC lifted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 14.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,552 shares of the company’s stock after buying an additional 1,071 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Acadia Healthcare were worth $578,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in Acadia Healthcare by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock worth $689,065,000 after purchasing an additional 30,296 shares in the last quarter. William Blair Investment Management LLC increased its stake in shares of Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after buying an additional 604,070 shares during the period. Bank of New York Mellon Corp raised its holdings in Acadia Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock valued at $84,382,000 after buying an additional 77,509 shares during the last quarter. Avidity Partners Management LP grew its holdings in Acadia Healthcare by 61.8% during the 4th quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock worth $89,944,000 after acquiring an additional 441,692 shares during the last quarter. Finally, Iron Triangle Partners LP increased its position in Acadia Healthcare by 14.0% in the 1st quarter. Iron Triangle Partners LP now owns 902,813 shares of the company’s stock valued at $71,521,000 after acquiring an additional 110,820 shares during the period.

Acadia Healthcare Stock Down 0.1 %

Shares of NASDAQ ACHC opened at $75.66 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. The firm has a market cap of $7.02 billion, a PE ratio of -540.43, a P/E/G ratio of 2.19 and a beta of 1.30. The company’s fifty day simple moving average is $74.26 and its 200 day simple moving average is $71.84. Acadia Healthcare Company, Inc. has a 12-month low of $62.04 and a 12-month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. During the same quarter in the prior year, the firm earned $0.92 EPS. The business’s revenue was up 8.8% on a year-over-year basis. As a group, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ACHC. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a report on Monday, August 19th. Barclays lowered their price objective on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Friday, September 20th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $87.44.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.